Chiralpak AD and Chiracel OD columns from Chiral Technology, Inc. have recently gained recognition in the separation of enantiomers of pharmaceutically important compounds [1][2][3][4][5][6][7][8][9]. Both columns have the same dimethylphenyl carbamate functionality; however, AD and OD are an amylose and a cellulose derivative, respectively. The Chiralcel OD column is marketed in both normal-phase mode (OD) and reversed-phase mode (OD-R). However, since the Chiralpak AD column was originally designed by the manufacturer to be used only in the normal-phase mode, there was very little literature on reversed-phase applications of Chiralpak AD columns in the early 1990s. The work presented here demonstrates the superior separations in the reversed-phase mode as compared to the normal-phase mode for Chiralpak AD columns.
PHASE-CONVERSION CHIRAL SEPARATIONSThree case studies of separations of pharmaceutical chiral intermediates in the reversed phase are illustrated below. A Chiralpak AD column was converted from the originally designed normal-phase to reversed-phase mode. To convert a chiral column in normal phase to the reversed phase, the column was flushed adequately with 200 proof ethanol at 0.2 mL/min (not exceeding the pressure limit of the column), then equilibrated in an organic and aqueous mixture of the reversed mobile phase. The characteristics of this new reversed-phase application are compared with those of the normal-phase mode.
Case Study 1The molecular structures of the first reversed-phase mode separation of pharmaceutical intermediates are as shown in Scheme 1. Compound
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.